Published in Psychopharmacology (Berl) on May 17, 2014
Opioid therapy for chronic pain. N Engl J Med (2003) 7.30
Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol (2007) 5.13
Opioid dependence and addiction during opioid treatment of chronic pain. Pain (2007) 4.33
Curcumin: the Indian solid gold. Adv Exp Med Biol (2007) 4.12
Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci (2008) 3.16
Addictive drugs and brain stimulation reward. Annu Rev Neurosci (1996) 3.12
Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol (2008) 2.95
Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc (2007) 2.63
The targets of curcumin. Curr Drug Targets (2011) 1.76
Opioids in pain management. Lancet (1999) 1.69
Opioid facilitation of rewarding electrical brain stimulation is suppressed in rats with neuropathic pain. Anesthesiology (2011) 1.59
Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pharmacol (2006) 1.55
Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc Natl Acad Sci U S A (2007) 1.52
Addiction to opioids in chronic pain patients: a literature review. Eur J Pain (2006) 1.51
Brain reward systems and compulsive drug use. Trends Pharmacol Sci (2007) 1.42
The curve-shift paradigm in self-stimulation. Physiol Behav (1986) 1.38
Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacol Biochem Behav (2008) 1.29
Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved. Neuropharmacology (2011) 1.29
Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (Berl) (2008) 1.21
Some determinants of morphine effects on intracranial self-stimulation in rats: dose, pretreatment time, repeated treatment, and rate dependence. Behav Pharmacol (2011) 1.16
Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat. Phytother Res (2009) 1.12
Studies on curcumin and curcuminoids XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin. Int J Pharm (2007) 1.09
Qualitative differences between C57BL/6J and DBA/2J mice in morphine potentiation of brain stimulation reward and intravenous self-administration. Psychopharmacology (Berl) (2009) 0.99
The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. Eur J Pharmacol (2007) 0.94
Nicotine alters limbic function in adolescent rat by a 5-HT1A receptor mechanism. Neuropsychopharmacology (2011) 0.93
Suppression of neuroinflammatory and apoptotic signaling cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depression. PLoS One (2013) 0.93
Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism. Psychopharmacology (Berl) (2011) 0.92
Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors. J Pharmacol Exp Ther (2001) 0.91
Parametric analysis of brain stimulation reward in the rat: III. Effect of performance variables on the reward summation function. J Comp Physiol Psychol (1974) 0.90
Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor. Psychopharmacology (Berl) (2013) 0.89
Role of serotonin 5-HT2A and 5-HT2C receptors on brain stimulation reward and the reward-facilitating effect of cocaine. Psychopharmacology (Berl) (2010) 0.89
Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. Brain Res (1993) 0.88
Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus. Addict Biol (2012) 0.86
Curcumin blocks chronic morphine analgesic tolerance and brain-derived neurotrophic factor upregulation. Neuroreport (2009) 0.86
The effect of curcumin (active substance of turmeric) on the acetic acid-induced visceral nociception in rats. Pak J Biol Sci (2008) 0.86
Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects. Brain Res (2005) 0.85
Neurodegenerative Shielding by Curcumin and Its Derivatives on Brain Lesions Induced by 6-OHDA Model of Parkinson's Disease in Albino Wistar Rats. Cardiovasc Psychiatry Neurol (2012) 0.83
Orally administered nanocurcumin to attenuate morphine tolerance: comparison between negatively charged PLGA and partially and fully PEGylated nanoparticles. Mol Pharm (2013) 0.82
Using a rate-frequency curve method to assess the rewarding properties of morphine in the intracranial self-stimulation paradigm in rats. J Neurosci Methods (2010) 0.82
Biphasic modulation of cocaine-induced conditioned place preference through inhibition of histone acetyltransferase and histone deacetylase. Saudi Med J (2010) 0.82
The 5-HT1A C(-1019)G polymorphism, personality and electrodermal reactivity in a reward/punishment paradigm. Int J Neuropsychopharmacol (2008) 0.82
Effects of concomitant motor reactions on the measurement of rewarding efficacy of brain stimulation. Behav Neurosci (1987) 0.80
Antidepressant-like effects of curcumin in chronic mild stress of rats: involvement of its anti-inflammatory action. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.80
A microcomputer-based method for physiologically interpretable measurement of the rewarding efficacy of brain stimulation. Physiol Behav (1985) 0.79
Evaluation of naturally occurring curcuminoids and related compounds against mosquito larvae. Acta Trop (2012) 0.77
Effects of the non-competitive NMDA-receptor antagonist memantine on morphine- and cocaine-induced potentiation of lateral hypothalamic brain stimulation reward. Psychopharmacology (Berl) (2000) 0.77
Herbals and natural dietary supplements in psychiatric practice. Recent Pat CNS Drug Discov (2010) 0.77
Chronic treatment with curcumin enhances methamphetamine locomotor sensitization and cue-induced reinstatement of methamphetamine self-administration. Pharmacol Biochem Behav (2012) 0.76
Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy. Hum Psychopharmacol (2009) 1.00
CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat. Psychopharmacology (Berl) (2004) 0.96
Lack of evidence for appetitive effects of Delta 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents. Behav Pharmacol (2007) 0.90
Synthesis and characterization of fac-[M(CO)3(P)(OO)] and cis-trans-[M(CO)2(P)2(OO)] complexes (M = Re, (99m)Tc) with acetylacetone and curcumin as OO donor bidentate ligands. Inorg Chem (2013) 0.90
Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity. Int J Neuropsychopharmacol (2013) 0.89
Role of serotonin 5-HT2A and 5-HT2C receptors on brain stimulation reward and the reward-facilitating effect of cocaine. Psychopharmacology (Berl) (2010) 0.89
Evaluation of Re and (99m)Tc complexes of 2-(4'-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals. J Med Chem (2010) 0.88
Synthesis, characterization, and biological evaluation of M(I)(CO)3(NNO) complexes (M = Re, 99mTc) conjugated to 2-(4-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals. J Med Chem (2006) 0.87
Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus. Addict Biol (2012) 0.86
Effects of endocannabinoid neurotransmission modulators on brain stimulation reward. Psychopharmacology (Berl) (2006) 0.86
Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine. Int J Neuropsychopharmacol (2008) 0.85
WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation. Behav Brain Res (2003) 0.85
The multiple T-maze in vivo testing of the neuroprotective effect of humanin analogues. Peptides (2008) 0.84
Solution structure of humanin, a peptide against Alzheimer's disease-related neurotoxicity. Biochem Biophys Res Commun (2005) 0.84
Curcumin as the OO bidentate ligand in "2 + 1" complexes with the [M(CO)3]+ (M = Re, 99mTc) tricarbonyl core for radiodiagnostic applications. Inorg Chem (2011) 0.84
High-Resolution NMR Spectroscopy of the beta-Amyloid(1-28) Fibril Typical for Alzheimer's Disease. Angew Chem Int Ed Engl (2001) 0.81
Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania. Int J Neuropsychopharmacol (2010) 0.81
Multiple sclerosis, cannabinoids, and cognition. J Neuropsychiatry Clin Neurosci (2008) 0.81
Novel aldose reductase inhibitors: a patent survey (2006--present). Expert Opin Ther Pat (2012) 0.80
Structural assessment and biological evaluation of two N3S bombesin derivatives. J Med Chem (2009) 0.80
Enhanced reward-facilitating effects of d-amphetamine in rats in the quinpirole model of obsessive-compulsive disorder. Int J Neuropsychopharmacol (2012) 0.79
Structural study by NMR of an oxorhenium-RGD decapeptide complex for application in radiotherapy. Inorg Chem (2004) 0.78
Synthesis and characterization of rhenium and technetium-99m tricarbonyl complexes bearing the 4-[3-bromophenyl]quinazoline moiety as a biomarker for EGFR-TK imaging. Eur J Med Chem (2009) 0.78
Effects of mood stabilizers on brain reward processes in rats: studies using the intracranial self-stimulation paradigm. Eur Neuropsychopharmacol (2008) 0.78
5-HT2C receptor involvement in the control of persistence in the reinforced spatial alternation animal model of obsessive-compulsive disorder. Behav Brain Res (2013) 0.78
Synthesis and characterization of novel natural product-Gd(III) MRI contrast agent conjugates. Bioorg Med Chem Lett (2008) 0.77
Chronic WIN55,212-2 elicits sustained and conditioned increases in intracranial self-stimulation thresholds in the rat. Behav Brain Res (2010) 0.77
Solution structure of Ser14Gly-humanin, a potent rescue factor against neuronal cell death in Alzheimer's disease. Biochem Biophys Res Commun (2006) 0.77
Glucose-induced gradual phenotypic modulation of cultured human glomerular epithelial cells may be independent of Wilms' tumor 1 (WT1). BMC Cell Biol (2013) 0.76
Oleuropein, an anti-oxidant polyphenol constituent of olive promotes α-secretase cleavage of the amyloid precursor protein (AβPP). Cell Mol Neurobiol (2012) 0.76
Detection of interactions of the beta-amyloid peptide with small molecules employing transferred NOEs. J Pept Sci (2009) 0.75
New oxorhenium(V) complexes from the widely used diaminedithiol (DADT) ligand system. Inorg Chem (2002) 0.75
Synthesis and characterization of novel "3 + 2" oxorhenium complexes, ReO[SNO][NN]. Inorg Chem (2006) 0.75
Parameters optimization defined by statistical analysis for cysteine-dextran radiolabeling with technetium tricarbonyl core. Appl Radiat Isot (2011) 0.75
Novel oxorhenium and oxotechnetium MO(NS)(S)2 complexes in the development of 5-HT1A receptor imaging agents. J Inorg Biochem (2003) 0.75
In vitro binding and in vivo biodistribution studies of the neuroprotective peptide humanin using [125I]humanin derivatives. Peptides (2009) 0.75
Preparation and characterization of technetium and rhenium tricarbonyl complexes bearing the 4-nitrobenzyl moiety as potential bioreductive diagnostic radiopharmaceuticals. In vitro and in vivo studies. Eur J Med Chem (2007) 0.75
Complexes of an alpha thymosin derivative with ¹⁸⁵/¹⁸⁷Re and (⁹⁹m)Tc: structural analysis and initial biological evaluation. Chem Biol Drug Des (2012) 0.75
Oxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives. Inorg Chem (2006) 0.75
Convenient route leading to neutral fac-M(CO)3(NNO) complexes (M = Re, 99mTc) coupled to amine pharmacophores. Inorg Chem (2008) 0.75
Synthesis and characterization of novel oxotechnetium (99Tc and 99mTc) and oxorhenium complexes from the 2,2'-bipyridine (NN)/thiol (S) mixed-ligand system. Inorg Chem (2003) 0.75
Design and development of (99m)tc-'4+1'-labeled dextran-mannose derivatives as potential radiopharmaceuticals for sentinel lymph node detection. Cancer Biother Radiopharm (2013) 0.75
Use of cannabis enhances attentional inhibition. Hum Psychopharmacol (2012) 0.75